Press "Enter" to skip to content

Durvalumab and Chemotherapy Improves OS in Extensive-Stage SCLC – Targeted Oncology

admin 0

Durvalumab and Chemotherapy Improves OS in Extensive-Stage SCLC  Targeted Oncology

Frontline durvalumab led to a statistically significant and clinically meaningful improvement in overall survival (OS) in combination with etoposide and …

“liver cancer” – Google News

(Visited 1 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *